Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Clinical trial NCT06288360 · RECRUITING

Trial details

NCT number: NCT06288360
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Locally Advanced Cervical Cancer PD-L1 Negative Neoadjuvant Chemoimmunotherapy

Start date: 2024-09-12
Primary completion: 2025-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.